Analytical Data
-
基因名
STK19
- Application
-
别名
STK19; G11; RP1; Serine/threonine-protein kinase 19; EC 2.7.11.1; Protein G11; Protein RP1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P49842
-
表达区间
1-368 aa
-
氨基酸序列
MQKWFSAFDD AIIQRQWRAN PSRGGGGVSF TKEVDTNVAT GAPPRRQRVP GRACPWREPI RGRRGARPGG GDAGGTPGET VRHCSAPEDP IFRFSSLHSY PFPGTIKSRD MSWKRHHLIP ETFGVKRRRK RGPVESDPLR GEPGSARAAV SELMQLFPRG LFEDALPPIV LRSQVYSLVP DRTVADRQLK ELQEQGEIRI VQLGFDLDAH GIIFTEDYRT RVCDCVLKAC DGRPYAGAVQ KFLASVLPAC GDLSFQQDQM TQTFGFRDSE ITHLVNAGVL TVRDAGSWWL AVPGAGRFIK YFVKGRQAVL SMVRKAKYRE LLLSELLGRR APVVVRLGLT YHVHDLIGAQ LVDCISTTSG TLLRLPET
-
分子量
28.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STK19 is a member of the Serine/Threonine Kinase (STK) family, which plays crucial roles in various cellular processes, including cell growth, differentiation, and apoptosis. Recent research has shown that STK19 is potentially involved in several pathological conditions, including cancer and neurological disorders, making it a target of interest for therapeutic interventions. The exploration of STK19 recombinant protein has gained traction due to its potential implications in signal transduction pathways that are often dysregulated in disease states. By producing STK19 as a recombinant protein, researchers aim to investigate its functional properties, structural characteristics, and interactions with other signaling molecules. This endeavor not only enhances our understanding of STK19’s biological roles but also paves the way for the development of novel drugs targeting STK19-related pathways. Moreover, understanding the post-translational modifications and regulatory mechanisms of STK19 at the molecular level could provide insights into its function and its role in diseases, thus potentially contributing to new strategies for diagnosis and treatment. Therefore, further studies on the recombinant expression and characterization of STK19 are vital for elucidating its biological significance and therapeutic potential in various contexts.
